Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

2050038-84-9 manufacturers and suppliers on PharmaCompass

PharmaCompass
2050038-84-9
Also known as: 2050038-84-9, 8-[(3r,4s)-4-ethyl-3-pyrrolidinyl]-3h-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine dihydrochloride, 12-[(3r,4s)-4-ethylpyrrolidin-3-yl]-1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaene;dihydrochloride, 3h-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine, 8-[(3r,4s)-4-ethyl-3-pyrrolidinyl]-, hydrochloride (1:2), Amy16529, Db-156747
Molecular Formula
C14H19Cl2N5
Molecular Weight
328.2  g/mol
InChI Key
LKVHWZCFMAQTFX-NKRBYZSKSA-N

1 2D Structure

2050038-84-9

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
12-[(3R,4S)-4-ethylpyrrolidin-3-yl]-1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaene;dihydrochloride
2.1.2 InChI
InChI=1S/C14H17N5.2ClH/c1-2-9-5-15-6-10(9)12-7-17-13-8-18-14-11(19(12)13)3-4-16-14;;/h3-4,7-10,15-16H,2,5-6H2,1H3;2*1H/t9-,10+;;/m1../s1
2.1.3 InChI Key
LKVHWZCFMAQTFX-NKRBYZSKSA-N
2.1.4 Canonical SMILES
CCC1CNCC1C2=CN=C3N2C4=C(NC=C4)N=C3.Cl.Cl
2.1.5 Isomeric SMILES
CC[C@@H]1CNC[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3.Cl.Cl
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 2050038-84-9

2. 8-[(3r,4s)-4-ethyl-3-pyrrolidinyl]-3h-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine Dihydrochloride

3. 12-[(3r,4s)-4-ethylpyrrolidin-3-yl]-1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaene;dihydrochloride

4. 3h-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine, 8-[(3r,4s)-4-ethyl-3-pyrrolidinyl]-, Hydrochloride (1:2)

5. Amy16529

6. Db-156747

7. 8-((3r,4s)-4-ethyl-3-pyrrolidinyl)-3h-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine 2hcl

8. 12-[(3r,4s)-4-ethylpyrrolidin-3-yl]-1,5,7,10-tetraazatricyclo[7.3.0.0,dodeca-2(6),3,7,9,11-pentaene Dihydrochloride

2.3 Create Date
2019-12-06
3 Chemical and Physical Properties
Molecular Weight 328.2 g/mol
Molecular Formula C14H19Cl2N5
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area58
Heavy Atom Count21
Formal Charge0
Complexity336
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
Flag China
Digital Content Digital Content
1428243-26-8
Upadacitinib
Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) ...
Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include customized R&D as well as the production of small molecule pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs) for both international and domestic pharmaceutical firms. Our capabilities span from laboratory-scale kilograms to commercial ton-scale production. Additionally, we are committed to independent research and development, as well as the production and sales of high-end pharmaceutical intermediates and API products.
Flag China
Digital Content Digital Content
1201187-44-1
Upadacitinib
Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) ...
Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include customized R&D as well as the production of small molecule pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs) for both international and domestic pharmaceutical firms. Our capabilities span from laboratory-scale kilograms to commercial ton-scale production. Additionally, we are committed to independent research and development, as well as the production and sales of high-end pharmaceutical intermediates and API products.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY